Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Brenner, Barry M., Cooper, Mark E., de Zeeuw, Dick, Keane, William F., Mitch, William E., Parving, Hans-Henrik, Remuzzi, Giuseppe, Snapinn, Steven M., Zhang, Zhonxin, Shahinfar, Shahnaz·2001·New England Journal of Medicine

DOI 10.1056/nejmoa011161

Cited by (7,495)

Items 301–400 of 7,495

Sodium Intake, ACE Inhibition, and Progression to ESRD
Stefan Vegter, Annalisa Perna, Maarten Jacobus Postma, Gerjan J Navis, Giuseppe Remuzzi, Piero Luigi Ruggenenti · 2011 · Journal of the American Society of Nephrology
Inflammation, oxidative stress and renin angiotensin system in atherosclerosis
Kazim M. Husain · 2015 · World Journal of Biological Chemistry
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
John J.V. McMurray, Hertzel C. Gerstein, Rury R. Holman, Marc Alan Pfeffer · 2014 · The Lancet Diabetes & Endocrinology
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
H.‐H. Parving, Barry Morton Brenner, John J.V. McMurray, Dick de Zeeuw, Steven M. Haffner, Scott David Solomon, Nish Chaturvedi, Mathieu M. Ghadanfar, Nicole Weissbach, Z. Xiang et al. · 2009 · Nephrology Dialysis Transplantation
Algorithms for the Automated Detection of Diabetic Retinopathy Using Digital Fundus Images: A Review
Oliver Faust, U. Rajendra Acharya, E. Y. K. Ng · 2010 · Journal of Medical Systems
Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons
Takashige Kuwabara, Kiyoshi Mori, Masashi Mukoyama, Masato Kasahara, Hideki Yokoi, Yoko Saito, Tetsuro Yoshioka, Yoshihisa Ogawa, Hirotaka Imamaki, Toru Kusakabe et al. · 2009 · Kidney International
Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy
Wouter B.A. Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, Hans‐Henrik Parving, Mark Emmanuel Cooper, William F. Keane, Shahnaz Shahinfar, Gilbert W. Gleim, Matthew R. Weir, Barry Morton Brenner et al. · 2007 · Journal of the American Society of Nephrology
10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association · 2017 · Diabetes Care
Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide
Thanasekaran Jayakumar, Cheng‐Ying Hsieh, Jie-Jen Lee, Joen‐Rong Sheu · 2013 · Evidence-based Complementary and Alternative Medicine
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Gavin Y. Oudit, George C. Liu, Jiuchang Zhong, Ratnadeep Basu, Fung Lan Chow, Joyce Zhou, Hans Loibner, Evelyne Janzek, Manfred Schuster, Josef Martin Penninger et al. · 2009 · Diabetes
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
Katherine R. Tuttle, George L. Bakris, Robert D. Toto, Janet B. McGill, Kuolung Hu, Pamela W. Anderson · 2005 · Diabetes Care
Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy
Kasper Rossing, Katrine Jordan Schjoedt, U. Smidt, Frans Boomsma, Hans‐Henrik Parving · 2005 · Diabetes Care
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Peter Stenvinkel, Glenn Matthew Chertow, Prasad Devarajan, Adeera Levin, Sharon Phillips Andreoli, Sripal Bangalore, Bradley A. Warady · 2021 · Kidney International Reports
I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica
Maria Helena Catelli de Carvalho, Márcio C. Mancini, Maria Edna de Melo, Luciana Bahia, Carlos Eduardo Negrão, Luciana Diniz Nagem Janot de Matos, Antônio Felipe Sanjuliani, Osvaldo Kohlmann, José Egídio Paulo De Oliveira, Antônio Carlos Lerário et al. · 2005 · Arquivos Brasileiros de Cardiologia
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Andrew S. Levey, Daniel C. Cattran, Aaron L. Friedman, W. Greg Miller, John R. Sedor, Katherine R. Tuttle, B.L. Kasiske, Thomas H. Hostetter · 2009 · American Journal of Kidney Diseases
The Relationship Between Magnitude of Proteinuria Reduction and Risk of End-stage Renal Disease
Janice P. Lea · 2005 · Archives of Internal Medicine
Diabetic nephropathy: diagnosis and treatment
Daniel Fineberg, Karin Agnes Maria Jandeleit-Dahm, Mark Emmanuel Cooper · 2013 · Nature Reviews Endocrinology
Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
Per‐Henrik Groop, Mark Emmanuel Cooper, Vlado Perkovic, Angela Emser, Hans‐Juergen Woerle, Maximilian von Eynatten · 2013 · Diabetes Care
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
Scheen, Andr?? J · 2004 · Drugs
Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
Helmy M. Siragy, Robert M. Carey · 2010 · American Journal of Nephrology
KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease
Yutaro Mori, Amrendra K. Ajay, Jae‐Hyung Chang, Shan Mou, Huiping Zhao, Seiji Kishi, Jiahua Li, Craig R. Brooks, Sheng Xiao, Heung‐Myong Woo et al. · 2021 · Cell Metabolism
Cardiovascular Complications of Diabetic Kidney Disease
Ragnar Pálsson, Uptal D. Patel · 2014 · Advances in Chronic Kidney Disease
Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression
Sandra Naaman, George L. Bakris · 2023 · Diabetes Care
Carnosine as a Protective Factor in Diabetic Nephropathy
Bart J. Janssen, Daniela Hohenadel, Paul Thomas Brinkkoetter, Verena Peters, Nina Rind, Christine Fischer, Ivan Rychlík, Marie Černá, Marianna Romžová, Emile de Heer et al. · 2005 · Diabetes
Diabetic Nephropathy and Extracellular Matrix
Svein O. Kolset, Finn Per Reinholt, Trond Geir Jenssen · 2012 · Journal of Histochemistry & Cytochemistry
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
Zhongyi Zhang, Yan Zhang, Gang Ning, Dilip K. Deb, Juan Kong, Yan Chun Li · 2008 · Proceedings of the National Academy of Sciences
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications
Günter Wolf, Eberhard Ritz · 2005 · Kidney International
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana M. Isaacs, Eric L. Johnson et al. · 2022 · Diabetes Care
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial
Christopher J. Cooper, Timothy P. Murphy, Alan H. Matsumoto, Michael W. Steffes, David J. Cohen, Michael R. Jaff, Richard E. Kuntz, Kenneth Jamerson, Diane Reid, Kenneth Rosenfield et al. · 2006 · American Heart Journal
Mechanisms and Treatment of CKD
Piero Luigi Ruggenenti, Paolo Cravedi, Giuseppe Remuzzi · 2012 · Journal of the American Society of Nephrology
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
Maartje C.J. Slagman, Femke Waanders, Marc H. Hemmelder, Arend-Jan J. Woittiez, W. M. T. Janssen, Hiddo J.L. Heerspink, G. J. Navis, Gozewijn Dirk Laverman, for the HONEST (HOlland NEphrology STudy) Group · 2011 · BMJ
Impact of genetic background on nephropathy in diabetic mice
Susan B. Gurley, Sharon E. Clare, Kamie P. Snow, Ann Hu, Timothy W. Meyer, Thomas M. Coffman · 2005 · American Journal of Physiology-Renal Physiology
Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Ian D. Graham, Dan Atar, Knut Borch‐Johnsen, Gudrun Boysen, Gunilla K Burell, Renata Cífková, Jean Dallongeville, Guy De Backer, Shah B J Ebrahim, Bjørn Gjelsvik et al. · 2007 · European Journal of Cardiovascular Prevention & Rehabilitation
Prorenin Receptor Blockade Inhibits Development of Glomerulosclerosis in Diabetic Angiotensin II Type 1a Receptor–Deficient Mice
Atsuhiro Ichihara, Fumiaki Suzuki, Tsutomu Nakagawa, Yuki Kaneshiro, Tomoko Yamashita Takemitsu, Mariyo Sakoda, A.H.M. Nurun Nabi, Akira Nishiyama, Takeshi Sugaya, Matsuhiko Hayashi et al. · 2006 · Journal of the American Society of Nephrology
Surrogate Markers for Cardiovascular Disease
Jay N. Cohn, Arshed Ali Quyyumi, Norman K. Hollenberg, Kenneth Jamerson · 2004 · Circulation
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle, Frank Chip Brosius, Sharon G. Adler, Matthias Kretzler, Ravindra L. Mehta, James Alan Tumlin, Yoshiya Tanaka, Masakazu Haneda, Jiajun Liu, Maria E. Silk et al. · 2017 · Nephrology Dialysis Transplantation
Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats
David L. Feldman, Liang Jin, Hong Xuan, Aurélie Contrepas, Yinong Zhou, Randy L. Webb, Dominik N. Mueller, Sandra Feldt, Frederick Cumin, Wieslawa M. Maniara et al. · 2008 · Hypertension
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients
Reboldi, Gianpaolo, Gentile, Giorgio, Angeli, Fabio, Ambrosio, Giuseppe, Mancia, Giuseppe, Verdecchia, Paolo · 2011 · Journal of Hypertension
Serum Bicarbonate Levels and the Progression of Kidney Disease: A Cohort Study
Samir N. Shah, Matthew K. Abramowitz, Thomas H. Hostetter, Michal L. Melamed · 2009 · American Journal of Kidney Diseases
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD
Gerald Schulman, Tomás Berl, Gerald J. Beck, Giuseppe Remuzzi, Eberhard Ritz, Kiyoshi Arita, Akira Kato, Miho Shimizu · 2014 · Journal of the American Society of Nephrology
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus
Jun Cheng, Wen Zhang, Xiaohui Zhang, Fei Han, Xiayu Li, Xuelin He, Qun Li, Jianghua Chen · 2014 · JAMA Internal Medicine
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function
Faiez M. Zannad, João Pedro Ferreira, Stuart Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos S Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr et al. · 2020 · Circulation
Effects of Antioxidants in Diabetes-Induced Oxidative Stress in the Glomeruli of Diabetic Rats
Daisuke Koya, Kazuyuki Hayashi, Munehiro Kitada, Atsunori Kashiwagi, Ryuichi Kikkawa, Masakazu Haneda · 2003 · Journal of the American Society of Nephrology
Reduction of the Accumulation of Advanced Glycation End Products by ACE Inhibition in Experimental Diabetic Nephropathy
Josephine Maree Forbes, Mark Emmanuel Cooper, Vicki Thallas, Wendy C. Burns, Merlin C. Thomas, Gail C. Brammar, Fiona Lee, Sharon L. Grant, Louise M. Burrell, George Jerums et al. · 2002 · Diabetes
Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Type 1 Receptor Antagonist Therapy Is Associated with Prolonged Patient and Graft Survival after Renal Transplantation
Georg Heinze, Christa Mitterbauer, Heinz M. Regele, Reinhard Kramar, Wolfgang C. Winkelmayer, Gary C. Curhan, Rainer W. Oberbauer · 2006 · Journal of the American Society of Nephrology
Effects of blood pressure lowering on outcome incidence in hypertension
Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2014 · Journal of Hypertension
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
James R. Voelker, Paul H. Berg, Matthew J. Sheetz, Kevin L. Duffin, Tong Shen, Brian A. Moser, Tom Greene, Samuel S. Blumenthal, Ivan Rychlík, Yoram Yagil et al. · 2016 · Journal of the American Society of Nephrology
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay et al. · 2023 · Diabetes Care
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
Guy De Backer, Ettore Ambrosioni, Knut Broch-Johnsen, Carlos Brotons, Renata Cífková, Jean Dallongeville, Shah B J Ebrahim, Ole Færgeman, Ian D. Graham, Guiseppe Mancia et al. · 2003 · European Journal of Cardiovascular Prevention & Rehabilitation
Aldosterone in the development and progression of renal injury
Norman K. Hollenberg · 2004 · Kidney International
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Denise Wong, Gavin Y. Oudit, Heather N. Reich, Zamaneh Kassiri, Joyce Zhou, Qiao C. Liu, Peter H. Backx, Josef Martin Penninger, Andrew M. Herzenberg, James William Scholey · 2007 · American Journal Of Pathology
The next generation of therapeutics for chronic kidney disease
Matthew Douglas Breyer, Katalin Suszták · 2016 · Nature Reviews Drug Discovery
Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
Bastiaan E. de Galan, Vlado Perkovic, Toshiharu Ninomiya, Avinesh Pillai, Anushka A Patel, Alan Cass, Bruce Charles Neal, Neil R Poulter, Stephen B. Harrap, Carl-Erik Mogensen et al. · 2009 · Journal of the American Society of Nephrology
Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort
Adeera Levin, Ognjenka Djurdjev, Monica Beaulieu, Lee Er · 2008 · American Journal of Kidney Diseases
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis
Κωνσταντίνος Τζιόμαλος, Vasilios Gabriel Athyros · 2015 · The Review of Diabetic Studies
Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology
Cecilia C. Low Wang, Marc Lee Goalstone, Boris Draznin · 2004 · Diabetes
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, Gilberta, Sechi, Leonardo A., Rilli, Silvia, Carey, Robert M. · 2005 · Trends in Endocrinology & Metabolism
Oxidative stress and the role of redox signalling in chronic kidney disease
Seiji Kishi, Hajime Nagasu, Kengo Kidokoro, Naoki Kashihara · 2023 · Nature Reviews Nephrology
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Molitch, Mark E., Adler, Amanda I., Flyvbjerg, Allan, Nelson, Robert G., So, Wing-Yee, Wanner, Christoph, Kasiske, Bertram L., Wheeler, David C., de Zeeuw, Dick, Mogensen, Carl E. · 2015 · Kidney International
Is obesity a major cause of chronic kidney disease?
Hall, John E, Henegar, Jeffrey R, Dwyer, Terry M, Liu, Jiankang, da Silva, Alexandre A, Kuo, Jay J, Tallam, Lakshmi · 2004 · Advances in Renal Replacement Therapy
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
Steven G. Chrysant, Michael R. Melino, Sulekha Karki, James Lee, Reinilde Heyrman · 2008 · Clinical Therapeutics
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
Petra Zürbig, George Jerums, Peter Hambak Hovind, Richard J. MacIsaac, Harald Mischak, Stine Elkjaer Nielsen, Sianna Panagiotopoulos, Frederik Persson, Peter R Rossing · 2012 · Diabetes
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease
Sankar Dass Navaneethan, Sagar U. Nigwekar, Ashwini R. Sehgal, Giovanni FM Strippoli · 2009 · Clinical Journal of the American Society of Nephrology
Systolic and diastolic blood pressure control in antihypertensive drug trials
Giuseppe Mancia, Guido M. Grassi · 2002 · Journal of Hypertension
The Past 200 Years in Diabetes
Kenneth S. Polonsky · 2012 · New England Journal of Medicine
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
Youhua Liu · 2004 · American Journal of Physiology-Renal Physiology
Standards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association · 2002 · Diabetes Care
Liver Angiotensinogen Is the Primary Source of Renal Angiotensin II
Taiji Matsusaka, Fumio Niimura, Akihiro Shimizu, Ira H Pastan, Akihiko Saito, Hiroyuki Kobori, Akira Nishiyama, Iekuni Ichikawa · 2012 · Journal of the American Society of Nephrology
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, Nuha A., McCoy, Rozalina G., Aleppo, Grazia, Balapattabi, Kirthikaa, Beverly, Elizabeth A., Briggs Early, Kathaleen, Bruemmer, Dennis, Echouffo-Tcheugui, Justin B., Ekhlaspour, Laya et al. · 2025 · Diabetes Care
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials
Blood Pressure Lowering Treatment Trialists' Collaboration · 2013 · BMJ
Chronic kidney disease and cardiovascular complications
Luca Di Lullo, Andrew A. House, Antonio Gorini, Alberto Santoboni, Domenico Russo, Claudio Ronco · 2014 · Heart Failure Reviews
Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
Sandeep S. Vijan, Rodney A. Hayward · 2003 · Annals of Internal Medicine
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease Prior to Dialysis
Adeera Levin · 2003 · Seminars in Dialysis
Clinical Pharmacokinetics of Losartan
Domenic A. Sica, Todd W.B. Gehr, Siddhartha S. Ghosh · 2005 · Clinical Pharmacokinetics
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, Danyi, Livingston, Man J., Liu, Zhiwen, Dong, Guie, Zhang, Ming, Chen, Jian-Kang, Dong, Zheng · 2018 · Cellular and Molecular Life Sciences
Treatment of Hypertension in Patients With Coronary Artery Disease
Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger Scott Blumenthal, Christopher Paul Cannon, James A. de Lemos, W.J. Elliott, Laura Findeiss et al. · 2015 · Circulation
Pathophysiology of the Diabetic Kidney
Volker Vallon, Radko Komers · 2011 · Comprehensive physiology
Early chronic kidney disease: diagnosis, management and models of care
Olivier J. Wouters, Donal J. O'Donoghue, James P. Ritchie, Panos G. Kanavos, Andrew S. Narva · 2015 · Nature Reviews Nephrology
AT 1A Angiotensin Receptors in the Renal Proximal Tubule Regulate Blood Pressure
Susan B. Gurley, Anne Riquier‐Brison, Jurgen B. Schnermann, Matthew A. Sparks, Andrew Mark Allen, Volker H. Haase, John N. Snouwaert, Thu H. Le, Alicia Ann McDonough, Beverly H. Koller et al. · 2011 · Cell Metabolism
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers
Hiddo J.L. Heerspink, Frank A. Holtkamp, Hans‐Henrik Parving, Gerjan J Navis, Julia Breyer Lewis, Eberhard Ritz, Pieter A. de Graeff, Dick de Zeeuw · 2012 · Kidney International
Hyperkalemia risk with finerenone: results from the FIDELIO-DKD Trial
Agarwal, Rajiv, Joseph, Amer, Anker, Stefan D., Filippatos, Gerasimos, Rossing, Peter, Ruilope, Luis M., Pitt, Bertram, Kolkhof, Peter, Scott, Charlie, Lawatscheck, Robert et al. · 2022 · Journal of the American Society of Nephrology
Diabetic nephropathy and transforming growth factor-β: transforming our view of glomerulosclerosis and fibrosis build-up
Sheldon Chen, Belinda Jim, Fuad N. Ziyadeh · 2003 · Seminars in Nephrology
Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management
Peter Noel Van Buren, Robert Toto · 2011 · Advances in Chronic Kidney Disease
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
Ron T. Gansevoort, Mustafa Arıcı, Thomas R. Benzing, Henrik Birn, Giovambattista Capasso, Adrian Constantin Covic, Olivier Devuyst, Christiane Drechsler, Kai‐Uwe Eckardt, Francesco Emma et al. · 2016 · Nephrology Dialysis Transplantation
Renin inhibition with aliskiren: where are we now, and where are we going?
Michel Azizi, Randy L. Webb, Juerg Nussberger, Norman K. Hollenberg · 2006 · Journal of Hypertension
Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy
Mark E. Williams, Warren Kline Bolton, Raja G. Khalifah, Thorsten P. Degenhardt, Robert J. Schotzinger, Janet B. McGill · 2007 · American Journal of Nephrology
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
Jonatan Barrera‐Chimal, Ixchel Lima‐Posada, George L. Bakris, Frédéric Jaisser · 2021 · Nature Reviews Nephrology
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
Heather N. Reich, Gavin Y. Oudit, Josef Martin Penninger, James William Scholey, Andrew M. Herzenberg · 2008 · Kidney International
Lymphocyte responses exacerbate angiotensin II-dependent hypertension
Steven D. Crowley, Young-Soo Song, Eugene E. Lin, Robert Griffiths, Hyung‐Suk Kim, Phillip Ruiz · 2010 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes
Rudy Bilous, Nish Chaturvedi, Anne Katrin Sjølie, John Fuller, Ronald Klein, Trevor Orchard, Massimo Porta, Hans-Henrik Parving · 2009 · Annals of Internal Medicine
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
Ashish M. Kamat, Thomas W. Flaig, H. Barton Grossman, Badrinath R. Konety, Donald L. Lamm, Michael A. O’Donnell, Edward Uchio, Jason Alexander Efstathiou, John Arthur Taylor · 2015 · Nature Reviews Urology
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials
Fiona Turnbull, Mark Woodward, Bruce Charles Neal, Federica Barzi, Toshiharu Ninomiya, John Philip Chalmers, Vlado Perkovic, Nicole Li, Stephen W MacMahon · 2008 · European Heart Journal
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Jones, Daniel W., Ferdinand, Keith C., Taler, Sandra J., Johnson, Heather M., Shimbo, Daichi, Abdalla, Marwah, Altieri, M. Martine, Bansal, Nisha, Bello, Natalie A., Bress, Adam P. et al. · 2025 · JACC
Epidemiological features of CKD in Taiwan.
Hsin-Wei Kuo, S. Tsai, M. Tiao, Chun-Yuh Yang · 2007 · American Journal of Kidney Diseases
Earlier Onset of Complications in Youth With Type 2 Diabetes
Allison B. Dart, Patricia Joan Martens, Claudio Rigatto, Marni D Brownell, Heather Dean, Elizabeth A. C. Sellers · 2013 · Diabetes Care
Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study
Fan Fan Hou, Di Xie, Xun Zhang, Ping Yan Chen, Wei Ru Zhang, Min Liang, Zhi Jian Guo, Jian Ping Jiang · 2007 · Journal of the American Society of Nephrology
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
Gavin C. Higgins, Melinda T. Coughlan · 2013 · British Journal of Pharmacology
Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
Jinhua Li, Xinli Qu, Jun Yao, Georgina Caruana, Sharon D. Ricardo, Yasuhiko Yamamoto, Hiroshi Yamamoto, John F. Bertram · 2010 · Diabetes
An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study
for the MAPS Investigators, A. Y. T. Wu, Norella C. T. Kong, F. A. de Leon, Changyu Pan, T Y Tai, Ming Wai Yeung, Soon Jib Yoo, A. Rouillon, Matthew R. Weir · 2004 · Diabetologia
Standards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association · 2002 · Diabetes Care